These tech giants will almost certainly be worth a lot more 10 years from now. There’s a saying that I think every investor should
Trump calls for credit card interest rate cap: Options for consumers if credit tightens
On Friday, Jan. 9, President Trump shared a message on Truth Social calling for a credit card interest rate cap starting Jan. 20, 2026
Should You Wait Until 70 to Claim Social Security? Here's What The Math Really Says
Ashley Donohoe, MBA, FPWM®, CFEI® January 12, 2026 at 2:30 PM When you’re planning for retirement, Social Security plays a key role in deciding
Why Trump Media stock surged 14.7% last month and has kept rising in 2026
Trump Media stock saw gains in conjunction with the acquisition news. Trump Media stock got a big boost in 2025’s final month after the
Stock Market Today Jan 9: Why Gold, S&P 500, and Nasdaq Prices are Surging?
Gold, S&P 500, and Nasdaq surge as weak jobs data boost rate-cut hopes ahead of key inflation and earnings reports.
Stock Market LIVE: GIFT Nifty hints higher open on US-India trade talk hopes; Asian mkts gain
Stock Market LIVE Updates: On Wall Street, the S&P 500 and the Dow Jones closed at fresh record highs overnight. The S&P 500 edged
Why the Dow, S&P 500 just closed at record highs despite Trump’s new pressure campaign against Fed’s Powell
Major U.S. equities benchmarks were trying to shake off the news in late-morning trade, with the Dow Jones Industrial Average shedding 0.1%, the S&P
S&P 500, Dow hit closing record highs; Walmart, tech climb
The S&P 500 and Dow hit record highs Monday, with tech and Walmart shares climbing despite a Justice Department probe into Fed Chair Powell.
Nifty 50, Sensex today: What to expect from Indian stock market in trade on January 13 amid volatile gold, silver prices
The trends on Gift Nifty also indicate a mildly positive start for the Indian benchmark index. The Gift Nifty was trading around 25,910 level,
Mirum Director Sells $400K Amid 91% Stock Surge — Here’s What the Firm Expects for 2026
Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.